Search research articles
Contact Us
Filters
Showing results (881-890 of 920) with videos related to
Page
of 92
Sort By:
Rare Tumors
|
August 6, 2024
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort
Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, et al.
Scientific Reports
|
September 17, 2024
Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response
R F Valenzuela, E Duran-Sierra, M Canjirathinkal, et al.
Clinical Sarcoma Research
|
January 1, 2013
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy
Wei-Lien Wang, Daniela Katz, Dejka M Araujo, et al.
Cancer Research Communications
|
March 21, 2025
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
Joel S Benjamin, Abigail Jarret, Shashank Bharill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study
Alberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
Cancers
|
March 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, et al.
Cancer Treatment Reports
|
February 1, 1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas
J A Gottlieb, R S Benjamin, L H Baker, et al.
Journal of Chemical Information and Modeling
|
May 26, 2025
Active Learning-Guided Hit Optimization for the Leucine-Rich Repeat Kinase 2 WDR Domain Based on In Silico Ligand-Binding Affinities
Filipp Gusev, Evgeny Gutkin, Francesco Gentile, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
April 25, 2025
Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECIST
Raul F Valenzuela, Elvis Duran-Sierra, Mathew Antony, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Page
of 92
Search research articles
Search
Showing results (881-890 of 920) with videos related to
Sort By:
Page
of 92
Rare Tumors
|
August 6, 2024
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort
Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, et al.
Scientific Reports
|
September 17, 2024
Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response
R F Valenzuela, E Duran-Sierra, M Canjirathinkal, et al.
Clinical Sarcoma Research
|
January 1, 2013
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy
Wei-Lien Wang, Daniela Katz, Dejka M Araujo, et al.
Cancer Research Communications
|
March 21, 2025
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation
Joel S Benjamin, Abigail Jarret, Shashank Bharill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study
Alberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
Cancers
|
March 13, 2024
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, et al.
Cancer Treatment Reports
|
February 1, 1976
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas
J A Gottlieb, R S Benjamin, L H Baker, et al.
Journal of Chemical Information and Modeling
|
May 26, 2025
Active Learning-Guided Hit Optimization for the Leucine-Rich Repeat Kinase 2 WDR Domain Based on In Silico Ligand-Binding Affinities
Filipp Gusev, Evgeny Gutkin, Francesco Gentile, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
April 25, 2025
Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECIST
Raul F Valenzuela, Elvis Duran-Sierra, Mathew Antony, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Page
of 92